N@N

Andrew Fein Reiterated (AMLX) at Strong Buy and Held Target at $8 on, Jul 10th, 2024

Andrew Fein of HC Wainwright & Co., Reiterated "Amylyx Pharmaceuticals, Inc." (AMLX) at Strong Buy and Held Target at $8 on, Jul 10th, 2024.

Andrew has made no other calls on AMLX in the last 4 months.

There are 5 other peers that have a rating on AMLX. Out of the 5 peers that are also analyzing AMLX, 4 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Graig Suvannavejh of "Mizuho" Maintained at Hold with Decreased Target to $3 on, Tuesday, May 14th, 2024
• Joel Beatty of "Baird" Maintained at Hold with Decreased Target to $3 on, Thursday, April 11th, 2024
• Marc Goodman of "Leerink Partners" Downgraded from Buy to Hold on, Monday, March 11th, 2024
• Chris Shibutani of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $4 on, Monday, March 11th, 2024

This is the rating of the analyst that currently disagrees with Andrew

---

• Neena Bitritto-Garg of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $8 on, Monday, March 11th, 2024

Contributing Sources

---